In recent years, many studies have revealed that LGR5 is overexpressed in various types of tumors, including colorectal cancer[15], ovarian tumor[16], hepatocellular carcinoma[17], basal cell carcinoma[18], and esophageal adenocarcinoma[19]. Here, LGR5 is linked to hepatocellular carcinoma.